National Institute on Drug Abuse Keep your Brain Healthy - Keep your Body Healthy
Link to Home Page Link to About NIDA Link to Whats New Link to In the News Link to Publications Link to Spanish Publications Link to Funding Information
Go
Information for - see right links Student Information Index link Parent-Teacher Information Index link Researcher Information Index link


NIDA Home > About NIDA > Organization   

Initial Review Group / Committee Structure
gray line



[IRG Meeting Dates for 2003]


Office of Extramural Affairs Committees
Code Name of
Subcommittee		 Scientific Review Administrator Research Areas
NIDA/E Treatment Kesinee Nimit, M.D.
#301/435-1432
kn50b@nih.gov		 Behavioral and/or pharmacologic treatment, medication application, and marketed medications clinical trials
NIDA/F Health Services Mark Green, Ph.D.
#301/435-1431
mgreen1@nida.nih.gov
 Health services research including the organization, management, financing, delivery, effectiveness, and impact of the drug abuse health services delivery system
NIDA/K Training and Career Development Mark Swieter, Ph.D.
#301/435-1389
ms80x@nih.gov		 Review grant applications for fellowship, career development and institutional training in all areas of drug abuse research
NIDA/L Medication Development Khursheed Asghar, Ph.D.
#301/443-2620
ka18I@nih.gov		 Review grant and cooperative agreement applications and contract proposals that propose to design and develop compounds and dosage formulations related to the discovery of new pharmacotherapeutic agents for treating drug dependence
ZDA1 Special Emphasis Panel (SEP) Varies Special Emphasis Panels (SEPS) are committees that  meet for a special purpose, such as the review of RFA applications, Center applications, or applications in conflict-of-interest with one of the standing committees. 

Click here for rosters of review groups that are managed by the Center for Scientific Review or other Institutes.

For general committee information contact:

Ms. Camilla L. Holland,
NIDA Committee Management Officer
(301)435-1384.

For specific committee information contact the Scientific Review Administrator listed above.

Office Address:

National Institute on Drug Abuse Initial Review Group
Office of Extramural Affairs
National Institute on Drug Abuse
National Institutes of Health
Atrium Building
6101 Executive Boulevard
Room 200, MSC 8401
Bethesda, Maryland 20892-8401

About NIDA Contents
Advanced Search | FAQs | Accessibility | Site Map | Help | NIDA Home | Privacy Policy | FOIA (NIH) | Employment |
National Institutes of Health logo Department of Health and Human Services Logo

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, August 25, 2004.